(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | ||||||||
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | ||||||||
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | ||||||||
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Title of Each Class | Trading Symbol | Name of Each Exchange on Which Registered | ||||||
Emerging Growth Company |
Exhibit No. | Description | |||||||
99.1 | ||||||||
104 | Cover Page Interactive Data File (formatted as inline XBRL) |
Applied Materials, Inc. (Registrant) | ||||||||||||||
Date: | November 12, 2020 | By: | /s/ Teri A. Little | |||||||||||
Teri A. Little | ||||||||||||||
Senior Vice President, Chief Legal Officer and Corporate Secretary |
Change | ||||||||||||||||||||||||||||||||
Q4 FY2020 | Q4 FY2019 | FY2020 | FY2019 | Q4 FY2020 vs. Q4 FY2019 | FY2020 vs. FY2019 | |||||||||||||||||||||||||||
(In millions, except per share amounts and percentages) | ||||||||||||||||||||||||||||||||
Net sales | $ | 4,688 | $ | 3,754 | $ | 17,202 | $ | 14,608 | 25% | 18% | ||||||||||||||||||||||
Gross margin | 45.4 | % | 43.5 | % | 44.7 | % | 43.7 | % | 1.9 points | 1.0 points | ||||||||||||||||||||||
Operating margin | 27.4 | % | 23.0 | % | 25.4 | % | 22.9 | % | 4.4 points | 2.5 points | ||||||||||||||||||||||
Net income | $ | 1,131 | $ | 698 | $ | 3,619 | $ | 2,706 | 62% | 34% | ||||||||||||||||||||||
Diluted earnings per share | $ | 1.23 | $ | 0.75 | $ | 3.92 | $ | 2.86 | 64% | 37% | ||||||||||||||||||||||
Non-GAAP Adjusted Results | ||||||||||||||||||||||||||||||||
Non-GAAP adjusted gross margin | 45.7 | % | 43.8 | % | 45.1 | % | 44.0 | % | 1.9 points | 1.1 points | ||||||||||||||||||||||
Non-GAAP adjusted operating margin | 28.3 | % | 23.7 | % | 26.3 | % | 23.5 | % | 4.6 points | 2.8 points | ||||||||||||||||||||||
Non-GAAP adjusted net income | $ | 1,148 | $ | 744 | $ | 3,845 | $ | 2,875 | 54% | 34% | ||||||||||||||||||||||
Non-GAAP adjusted diluted EPS | $ | 1.25 | $ | 0.80 | $ | 4.17 | $ | 3.04 | 56% | 37% |
Semiconductor Systems | Q4 FY2020 | Q4 FY2019 | FY2020 | FY2019 | |||||||||||||||||||
(In millions, except percentages) | |||||||||||||||||||||||
Net sales | $ | 3,070 | $ | 2,302 | $ | 11,367 | $ | 9,027 | |||||||||||||||
Foundry, logic and other | 58 | % | 58 | % | 59 | % | 52 | % | |||||||||||||||
DRAM | 21 | % | 21 | % | 20 | % | 22 | % | |||||||||||||||
Flash memory | 21 | % | 21 | % | 21 | % | 26 | % | |||||||||||||||
Operating income | 1,059 | 641 | 3,714 | 2,464 | |||||||||||||||||||
Operating margin | 34.5 | % | 27.8 | % | 32.7 | % | 27.3 | % | |||||||||||||||
Non-GAAP Adjusted Results | |||||||||||||||||||||||
Non-GAAP adjusted operating income | $ | 1,073 | $ | 652 | $ | 3,778 | $ | 2,507 | |||||||||||||||
Non-GAAP adjusted operating margin | 35.0 | % | 28.3 | % | 33.2 | % | 27.8 | % |
Applied Global Services | Q4 FY2020 | Q4 FY2019 | FY2020 | FY2019 | |||||||||||||||||||
(In millions, except percentages) | |||||||||||||||||||||||
Net sales | $ | 1,106 | $ | 977 | $ | 4,155 | $ | 3,854 | |||||||||||||||
Operating income | 320 | 274 | 1,127 | 1,101 | |||||||||||||||||||
Operating margin | 28.9 | % | 28.0 | % | 27.1 | % | 28.6 | % | |||||||||||||||
Non-GAAP Adjusted Results | |||||||||||||||||||||||
Non-GAAP adjusted operating income | $ | 320 | $ | 274 | $ | 1,135 | $ | 1,101 | |||||||||||||||
Non-GAAP adjusted operating margin | 28.9 | % | 28.0 | % | 27.3 | % | 28.6 | % |
Display and Adjacent Markets | Q4 FY2020 | Q4 FY2019 | FY2020 | FY2019 | |||||||||||||||||||
(In millions, except percentages) | |||||||||||||||||||||||
Net sales | $ | 485 | $ | 457 | $ | 1,607 | $ | 1,651 | |||||||||||||||
Operating income | 95 | 96 | 291 | 294 | |||||||||||||||||||
Operating margin | 19.6 | % | 21.0 | % | 18.1 | % | 17.8 | % | |||||||||||||||
Non-GAAP Adjusted Results | |||||||||||||||||||||||
Non-GAAP adjusted operating income | $ | 98 | $ | 99 | $ | 304 | $ | 307 | |||||||||||||||
Non-GAAP adjusted operating margin | 20.2 | % | 21.7 | % | 18.9 | % | 18.6 | % |
Three Months Ended | Twelve Months Ended | ||||||||||||||||||||||
(In millions, except per share amounts) | October 25, 2020 | October 27, 2019 | October 25, 2020 | October 27, 2019 | |||||||||||||||||||
Net sales | $ | 4,688 | $ | 3,754 | $ | 17,202 | $ | 14,608 | |||||||||||||||
Cost of products sold | 2,558 | 2,120 | 9,510 | 8,222 | |||||||||||||||||||
Gross profit | 2,130 | 1,634 | 7,692 | 6,386 | |||||||||||||||||||
Operating expenses: | |||||||||||||||||||||||
Research, development and engineering | 560 | 515 | 2,234 | 2,054 | |||||||||||||||||||
Marketing and selling | 131 | 129 | 526 | 521 | |||||||||||||||||||
General and administrative | 156 | 126 | 567 | 461 | |||||||||||||||||||
Total operating expenses | 847 | 770 | 3,327 | 3,036 | |||||||||||||||||||
Income from operations | 1,283 | 864 | 4,365 | 3,350 | |||||||||||||||||||
Interest expense | 59 | 59 | 240 | 237 | |||||||||||||||||||
Interest and other income (loss), net | 19 | 35 | 41 | 156 | |||||||||||||||||||
Income before income taxes | 1,243 | 840 | 4,166 | 3,269 | |||||||||||||||||||
Provision for income taxes | 112 | 142 | 547 | 563 | |||||||||||||||||||
Net income | $ | 1,131 | $ | 698 | $ | 3,619 | $ | 2,706 | |||||||||||||||
Earnings per share: | |||||||||||||||||||||||
Basic | $ | 1.24 | $ | 0.76 | $ | 3.95 | $ | 2.89 | |||||||||||||||
Diluted | $ | 1.23 | $ | 0.75 | $ | 3.92 | $ | 2.86 | |||||||||||||||
Weighted average number of shares: | |||||||||||||||||||||||
Basic | 914 | 920 | 916 | 937 | |||||||||||||||||||
Diluted | 921 | 931 | 923 | 945 |
(In millions) | October 25, 2020 | October 27, 2019 | |||||||||
ASSETS | |||||||||||
Current assets: | |||||||||||
Cash and cash equivalents | $ | 5,351 | $ | 3,129 | |||||||
Short-term investments | 387 | 489 | |||||||||
Accounts receivable, net | 2,963 | 2,533 | |||||||||
Inventories | 3,904 | 3,474 | |||||||||
Other current assets | 764 | 581 | |||||||||
Total current assets | 13,369 | 10,206 | |||||||||
Long-term investments | 1,538 | 1,703 | |||||||||
Property, plant and equipment, net | 1,604 | 1,529 | |||||||||
Goodwill | 3,466 | 3,399 | |||||||||
Purchased technology and other intangible assets, net | 153 | 156 | |||||||||
Deferred income taxes and other assets | 2,223 | 2,031 | |||||||||
Total assets | $ | 22,353 | $ | 19,024 | |||||||
LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||||||
Current liabilities: | |||||||||||
Current portion of long-term debt | $ | — | $ | 600 | |||||||
Accounts payable and accrued expenses | 3,138 | 2,511 | |||||||||
Contract liabilities | 1,321 | 1,336 | |||||||||
Total current liabilities | 4,459 | 4,447 | |||||||||
Long-term debt, net of current portion | 5,448 | 4,713 | |||||||||
Income taxes payable | 1,206 | 1,275 | |||||||||
Other liabilities | 662 | 375 | |||||||||
Total liabilities | 11,775 | 10,810 | |||||||||
Total stockholders’ equity | 10,578 | 8,214 | |||||||||
Total liabilities and stockholders’ equity | $ | 22,353 | $ | 19,024 |
(In millions) | Three Months Ended | Twelve Months Ended | |||||||||||||||||||||
October 25, 2020 | October 27, 2019 | October 25, 2020 | October 27, 2019 | ||||||||||||||||||||
Cash flows from operating activities: | |||||||||||||||||||||||
Net income | $ | 1,131 | $ | 698 | $ | 3,619 | $ | 2,706 | |||||||||||||||
Adjustments required to reconcile net income to cash provided by operating activities: | |||||||||||||||||||||||
Depreciation and amortization | 97 | 92 | 376 | 363 | |||||||||||||||||||
Share-based compensation | 73 | 66 | 307 | 263 | |||||||||||||||||||
Deferred income taxes | (18) | (8) | 80 | 49 | |||||||||||||||||||
Other | 5 | — | 60 | (19) | |||||||||||||||||||
Net change in operating assets and liabilities | 27 | (22) | (638) | (115) | |||||||||||||||||||
Cash provided by operating activities | 1,315 | 826 | 3,804 | 3,247 | |||||||||||||||||||
Cash flows from investing activities: | |||||||||||||||||||||||
Capital expenditures | (162) | (97) | (422) | (441) | |||||||||||||||||||
Cash paid for acquisitions, net of cash acquired | — | — | (107) | (28) | |||||||||||||||||||
Proceeds from sales and maturities of investments | 366 | 555 | 1,754 | 1,940 | |||||||||||||||||||
Purchases of investments | (345) | (544) | (1,355) | (1,914) | |||||||||||||||||||
Cash used in investing activities | (141) | (86) | (130) | (443) | |||||||||||||||||||
Cash flows from financing activities: | |||||||||||||||||||||||
Debt borrowings, net of issuance costs | — | — | 2,979 | — | |||||||||||||||||||
Debt repayments | — | — | (2,882) | — | |||||||||||||||||||
Proceeds from common stock issuances | 83 | 72 | 174 | 145 | |||||||||||||||||||
Common stock repurchases | (50) | (500) | (649) | (2,403) | |||||||||||||||||||
Tax withholding payments for vested equity awards | (6) | (3) | (172) | (86) | |||||||||||||||||||
Payments of dividends to stockholders | (200) | (194) | (787) | (771) | |||||||||||||||||||
Cash used in financing activities | (173) | (625) | (1,337) | (3,115) | |||||||||||||||||||
Increase (decrease) in cash, cash equivalents and restricted cash equivalents | 1,001 | 115 | 2,337 | (311) | |||||||||||||||||||
Cash, cash equivalents and restricted cash equivalents—beginning of period | 4,465 | 3,014 | 3,129 | 3,440 | |||||||||||||||||||
Cash, cash equivalents and restricted cash equivalents — end of period | $ | 5,466 | $ | 3,129 | $ | 5,466 | $ | 3,129 | |||||||||||||||
Reconciliation of cash, cash equivalents, and restricted cash equivalents | |||||||||||||||||||||||
Cash and cash equivalents | $ | 5,351 | $ | 3,129 | $ | 5,351 | $ | 3,129 | |||||||||||||||
Restricted cash equivalents included in deferred income taxes and other assets | 115 | — | 115 | — | |||||||||||||||||||
Total cash, cash equivalents, and restricted cash equivalents | $ | 5,466 | $ | 3,129 | $ | 5,466 | $ | 3,129 | |||||||||||||||
Supplemental cash flow information: | |||||||||||||||||||||||
Cash payments for income taxes | $ | 23 | $ | 69 | $ | 542 | $ | 522 | |||||||||||||||
Cash refunds from income taxes | $ | 63 | $ | 2 | $ | 68 | $ | 22 | |||||||||||||||
Cash payments for interest | $ | 68 | $ | 76 | $ | 219 | $ | 219 |
(In millions) | Q4 FY2020 | Q4 FY2019 | FY2020 | FY2019 | |||||||||||||||||||
Unallocated net sales | $ | 27 | $ | 18 | $ | 73 | $ | 76 | |||||||||||||||
Unallocated cost of products sold and expenses | (145) | (99) | (533) | (322) | |||||||||||||||||||
Share-based compensation | (73) | (66) | (307) | (263) | |||||||||||||||||||
Total | $ | (191) | $ | (147) | $ | (767) | $ | (509) |
Q4 FY2020 | Q4 FY2019 | FY2020 | FY2019 | ||||||||||||||||||||
Net Sales by Geography (In millions) | |||||||||||||||||||||||
United States | 448 | 412 | 1,619 | 1,871 | |||||||||||||||||||
% of Total | 10 | % | 11 | % | 10 | % | 13 | % | |||||||||||||||
Europe | 206 | 147 | 736 | 820 | |||||||||||||||||||
% of Total | 4 | % | 4 | % | 4 | % | 6 | % | |||||||||||||||
Japan | 706 | 471 | 1,996 | 2,198 | |||||||||||||||||||
% of Total | 15 | % | 13 | % | 11 | % | 15 | % | |||||||||||||||
Korea | 719 | 471 | 3,031 | 1,929 | |||||||||||||||||||
% of Total | 15 | % | 13 | % | 18 | % | 13 | % | |||||||||||||||
Taiwan | 872 | 919 | 3,953 | 2,965 | |||||||||||||||||||
% of Total | 19 | % | 24 | % | 23 | % | 20 | % | |||||||||||||||
Southeast Asia | 161 | 135 | 411 | 548 | |||||||||||||||||||
% of Total | 3 | % | 3 | % | 2 | % | 4 | % | |||||||||||||||
China | 1,576 | 1,199 | 5,456 | 4,277 | |||||||||||||||||||
% of Total | 34 | % | 32 | % | 32 | % | 29 | % | |||||||||||||||
Employees (In thousands) | |||||||||||||||||||||||
Regular Full Time | 24.0 | 22.0 |
Three Months Ended | Twelve Months Ended | ||||||||||||||||||||||
(In millions, except percentages) | October 25, 2020 | October 27, 2019 | October 25, 2020 | October 27, 2019 | |||||||||||||||||||
Non-GAAP Adjusted Gross Profit | |||||||||||||||||||||||
Reported gross profit - GAAP basis | $ | 2,130 | $ | 1,634 | $ | 7,692 | $ | 6,386 | |||||||||||||||
Certain items associated with acquisitions1 | 12 | 9 | 37 | 37 | |||||||||||||||||||
Certain incremental expenses related to COVID-195 | — | — | 23 | — | |||||||||||||||||||
Non-GAAP adjusted gross profit | $ | 2,142 | $ | 1,643 | $ | 7,752 | $ | 6,423 | |||||||||||||||
Non-GAAP adjusted gross margin | 45.7 | % | 43.8 | % | 45.1 | % | 44.0 | % | |||||||||||||||
Non-GAAP Adjusted Operating Income | |||||||||||||||||||||||
Reported operating income - GAAP basis | $ | 1,283 | $ | 864 | $ | 4,365 | $ | 3,350 | |||||||||||||||
Certain items associated with acquisitions1 | 16 | 14 | 54 | 55 | |||||||||||||||||||
Acquisition integration and deal costs | 26 | 10 | 80 | 22 | |||||||||||||||||||
Certain incremental expenses related to COVID-195 | — | — | 30 | — | |||||||||||||||||||
Non-GAAP adjusted operating income | $ | 1,325 | $ | 888 | $ | 4,529 | $ | 3,427 | |||||||||||||||
Non-GAAP adjusted operating margin | 28.3 | % | 23.7 | % | 26.3 | % | 23.5 | % | |||||||||||||||
Non-GAAP Adjusted Net Income | |||||||||||||||||||||||
Reported net income - GAAP basis | $ | 1,131 | $ | 698 | $ | 3,619 | $ | 2,706 | |||||||||||||||
Certain items associated with acquisitions1 | 16 | 14 | 54 | 55 | |||||||||||||||||||
Acquisition integration and deal costs | 26 | 10 | 80 | 22 | |||||||||||||||||||
Certain incremental expenses related to COVID-195 | — | — | 30 | — | |||||||||||||||||||
Realized loss (gain) on strategic investments, net | — | — | (1) | (6) | |||||||||||||||||||
Unrealized loss (gain) on strategic investments, net | (7) | (5) | (8) | (30) | |||||||||||||||||||
Loss on early extinguishment of debt | — | — | 33 | — | |||||||||||||||||||
Income tax effect of share-based compensation2 | 13 | 4 | — | — | |||||||||||||||||||
Income tax effect of changes in applicable U.S. tax laws3 | — | — | — | (24) | |||||||||||||||||||
Income tax effects related to intra-entity intangible asset transfers | 10 | 6 | 114 | 62 | |||||||||||||||||||
Resolution of prior years’ income tax filings and other tax items | (36) | 20 | (41) | 95 | |||||||||||||||||||
Income tax effect of non-GAAP adjustments4 | (5) | (3) | (35) | (5) | |||||||||||||||||||
Non-GAAP adjusted net income | $ | 1,148 | $ | 744 | $ | 3,845 | $ | 2,875 |
1 | These items are incremental charges attributable to completed acquisitions, consisting of amortization of purchased intangible assets. | ||||
2 | GAAP basis tax benefit related to share-based compensation is recognized ratably over the fiscal year on a non-GAAP basis. | ||||
3 | Charges to income tax provision related to a one-time transition tax as a result of U.S. tax legislation. | ||||
4 | Adjustment to provision for income taxes related to non-GAAP adjustments reflected in income before income taxes. | ||||
5 | Temporary incremental employee compensation during the COVID-19 pandemic. |
Three Months Ended | Twelve Months Ended | ||||||||||||||||||||||
(In millions, except per share amounts) | October 25, 2020 | October 27, 2019 | October 25, 2020 | October 27, 2019 | |||||||||||||||||||
Non-GAAP Adjusted Earnings Per Diluted Share | |||||||||||||||||||||||
Reported earnings per diluted share - GAAP basis | $ | 1.23 | $ | 0.75 | $ | 3.92 | $ | 2.86 | |||||||||||||||
Certain items associated with acquisitions | 0.02 | 0.01 | 0.05 | 0.05 | |||||||||||||||||||
Acquisition integration and deal costs | 0.02 | 0.01 | 0.07 | 0.02 | |||||||||||||||||||
Certain incremental expenses related to COVID-19 | — | — | 0.03 | — | |||||||||||||||||||
Loss on early extinguishment of debt | — | — | 0.03 | — | |||||||||||||||||||
Unrealized loss (gain) on strategic investments, net | (0.01) | — | (0.01) | (0.03) | |||||||||||||||||||
Income tax effect of share-based compensation | 0.02 | — | — | — | |||||||||||||||||||
Income tax effect of changes in applicable U.S. tax laws | — | — | — | (0.03) | |||||||||||||||||||
Income tax effects related to intra-entity intangible asset transfers | 0.01 | 0.01 | 0.12 | 0.07 | |||||||||||||||||||
Resolution of prior years’ income tax filings and other tax items | (0.04) | 0.02 | (0.04) | 0.10 | |||||||||||||||||||
Non-GAAP adjusted earnings per diluted share | $ | 1.25 | $ | 0.80 | $ | 4.17 | $ | 3.04 | |||||||||||||||
Weighted average number of diluted shares | 921 | 931 | 923 | 945 |
Three Months Ended | Twelve Months Ended | ||||||||||||||||||||||
(In millions, except percentages) | October 25, 2020 | October 27, 2019 | October 25, 2020 | October 27, 2019 | |||||||||||||||||||
Semiconductor Systems Non-GAAP Adjusted Operating Income | |||||||||||||||||||||||
Reported operating income - GAAP basis | $ | 1,059 | $ | 641 | $ | 3,714 | $ | 2,464 | |||||||||||||||
Certain items associated with acquisitions1 | 12 | 11 | 41 | 43 | |||||||||||||||||||
Acquisition integration costs | 2 | — | 3 | — | |||||||||||||||||||
Certain incremental expenses related to COVID-192 | — | — | 20 | — | |||||||||||||||||||
Non-GAAP adjusted operating income | $ | 1,073 | $ | 652 | $ | 3,778 | $ | 2,507 | |||||||||||||||
Non-GAAP adjusted operating margin | 35.0 | % | 28.3 | % | 33.2 | % | 27.8 | % | |||||||||||||||
AGS Non-GAAP Adjusted Operating Income | |||||||||||||||||||||||
Reported operating income - GAAP basis | $ | 320 | $ | 274 | $ | 1,127 | $ | 1,101 | |||||||||||||||
Certain incremental expenses related to COVID-192 | — | — | 8 | — | |||||||||||||||||||
Non-GAAP adjusted operating income | $ | 320 | $ | 274 | $ | 1,135 | $ | 1,101 | |||||||||||||||
Non-GAAP adjusted operating margin | 28.9 | % | 28.0 | % | 27.3 | % | 28.6 | % | |||||||||||||||
Display and Adjacent Markets Non-GAAP Adjusted Operating Income | |||||||||||||||||||||||
Reported operating income - GAAP basis | $ | 95 | $ | 96 | $ | 291 | $ | 294 | |||||||||||||||
Certain items associated with acquisitions1 | 3 | 3 | 12 | 12 | |||||||||||||||||||
Acquisition integration costs | — | — | — | 1 | |||||||||||||||||||
Certain incremental expenses related to COVID-192 | — | — | 1 | — | |||||||||||||||||||
Non-GAAP adjusted operating income | $ | 98 | $ | 99 | $ | 304 | $ | 307 | |||||||||||||||
Non-GAAP adjusted operating margin | 20.2 | % | 21.7 | % | 18.9 | % | 18.6 | % | |||||||||||||||
1 | These items are incremental charges attributable to completed acquisitions, consisting of amortization of purchased intangible assets. | ||||
2 | Temporary incremental employee compensation during the COVID-19 pandemic. | ||||
Three Months Ended | |||||
(In millions, except percentages) | October 25, 2020 | ||||
Provision for income taxes - GAAP basis (a) | $ | 112 | |||
Income tax effect of share-based compensation | (13) | ||||
Income tax effects related to intra-entity intangible asset transfers | (10) | ||||
Resolutions of prior years’ income tax filings and other tax items | 36 | ||||
Income tax effect of non-GAAP adjustments | 5 | ||||
Non-GAAP adjusted provision for income taxes (b) | $ | 130 | |||
Income before income taxes - GAAP basis (c) | $ | 1,243 | |||
Certain items associated with acquisitions | 16 | ||||
Acquisition integration and deal costs | 26 | ||||
Unrealized loss (gain) on strategic investments, net | (7) | ||||
Non-GAAP adjusted income before income taxes (d) | $ | 1,278 | |||
Effective income tax rate - GAAP basis (a/c) | 9.0 | % | |||
Non-GAAP adjusted effective income tax rate (b/d) | 10.2 | % |